Nov-204

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameNov-204
Drug Alias Namerecombinant protein (Novacta)viral infection therapy (Novacta)Nov-0204
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovacta Biosystems Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovacta Biosystems Ltd
Active IndicationsN/A
Inactive IndicationsVirus Diseases

Other Information

ATC CodeN/A
Related LinksN/A